The Social Proxy Overview
The Social Proxy develops high-quality 5G and 4G mobile private proxies in the United States (New York and Texas), Germany, Austria, Israel, and the United Kingdom. The company's mobile proxies provide clients with an endless stream of IPs the same as those of real users and offer a feature-rich dashboard designed to help users create, grow, and manage new accounts.
Latest News
No news articles.
| Sector | Business Software |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Acquired |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 11-50
Web & Social Links
| Website | TheSocialProxy.com |
Locations
Rothschild Boulevard 45, Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
The Social Proxy Business
Sector
Business SoftwareIT, R&D & Data SolutionsData ArchitectureTarget Customer
Communication ServicesWireless & MobileCore Technology
Platforms & InterfacesAPITags (2)
4g-networks5g-networksThe Social Proxy Financials
Public Offering / Exit
The Social Proxy Lifecycle
All Events
The Social Proxy News
0 articlesNo news articles.
The Social Proxy Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 28 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
The Social Proxy Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 91/100 |
| Missing | tags, video or image, funding rounds, news, markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 516115086 |
| Creator | Tal Klinger |
| Creator email | tal@thesocialproxy.com |
| Last updater | Jenny Sotnik-Talisman |
| Updater email | genys30@yahoo.com |
| Last update | 2022-08-08T00:00:00.000Z |
| Created | 2021-10-03T00:00:00.000Z |
| Claimed | Yes |
| Status detail | Acquired by XTL Biopharmaceuticals on Aug, 2024 |